Lexicon Pharmaceuticals Inc (LXRX)
Fair Value-31.6% Downside
Overvalued
Analyst52.6% Upside
Market Cap1.106 B
P/E-42.1x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Overvalued Stocks
Rapid Revenue Growth
High-Momentum Stocks
High-Growth Small-Cap Stocks
Small-Cap Stocks
ANI Pharmaceuticals Inc (ANIP)
Fair Value44.6% Upside
Undervalued
Analyst37.7% Upside
Market Cap1.679 B
P/E20.2x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Rapid Revenue Growth
Small-Cap Stocks
CorMedix Inc (CRMD)
Fair Value27.0% Upside
Undervalued
Analyst102.4% Upside
Market Cap590 M
P/E3.2x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
Rapid Revenue Growth
High-Growth Small-Cap Stocks
Small-Cap Stocks
Harrow Health Inc (HROW)
Fair Value22.2% Upside
Undervalued
Analyst72.0% Upside
Market Cap1.485 B
P/E-98.1x
Yield0.0%
HealthGood
NASDAQ
Featured in
Rapid Revenue Growth
High-Beta Stocks
High-Beta Momentum
High-Growth Small-Cap Stocks
Small-Cap Stocks
Zevra Therapeutics Inc (ZVRA)
Fair Value8.6% Upside
Fair
Analyst137.2% Upside
Market Cap621.9 M
P/E5.3x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Rapid Revenue Growth
High-Growth Small-Cap Stocks
Small-Cap Stocks
Harmony Biosciences Holdings (HRMY)
Fair Value47.5% Upside
Undervalued
Analyst19.5% Upside
Market Cap2.258 B
P/E12.3x
Yield0.0%
HealthExcellent
NASDAQ
Featured in
Rapid Revenue Growth
Xeris Pharmaceuticals Inc (XERS)
Fair Value-8.4% Downside
Fair
Analyst39.1% Upside
Market Cap1.484 B
P/E122.5x
Yield0.0%
HealthGreat
NASDAQ
Featured in
Rapid Revenue Growth
High-Beta Stocks
High-Beta Momentum
High-Growth Small-Cap Stocks
Small-Cap Stocks
